These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 33488847)

  • 1.
    Trevisan RO; Santos MM; Desidério CS; Alves LG; de Jesus Sousa T; de Castro Oliveira L; Jaiswal AK; Tiwari S; Bovi WG; de Oliveira-Silva M; Costa-Madeira JC; Castellano LRC; Silva MV; Azevedo V; Rodrigues Junior V; Oliveira CJF; de Castro Soares S
    Dis Markers; 2020; 2020():9130719. PubMed ID: 33488847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.
    Bhatia V; Sinha M; Luxon B; Garg N
    Infect Immun; 2004 Nov; 72(11):6245-54. PubMed ID: 15501750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mining Trypanosoma cruzi Genome Sequences for Antigen Discovery and Vaccine Development.
    Teh-Poot C; Dumonteil E
    Methods Mol Biol; 2019; 1955():23-34. PubMed ID: 30868516
    [TBL] [Abstract][Full Text] [Related]  

  • 4. From genome screening to creation of vaccine against Trypanosoma cruzi by use of immunoinformatics.
    Teh-Poot C; Tzec-Arjona E; Martínez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Dumonteil E
    J Infect Dis; 2015 Jan; 211(2):258-66. PubMed ID: 25070943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved proteomic approach for the discovery of potential vaccine targets in Trypanosoma cruzi.
    Nakayasu ES; Sobreira TJ; Torres R; Ganiko L; Oliveira PS; Marques AF; Almeida IC
    J Proteome Res; 2012 Jan; 11(1):237-46. PubMed ID: 22115061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trypanosoma cruzi Tc24 Antigen Expressed and Orally Delivered by Schizochytrium sp. Microalga is Immunogenic in Mice.
    Ramos-Vega A; Monreal-Escalante E; Rosales-Mendoza S; Bañuelos-Hernández B; Dumonteil E; Angulo C
    Mol Biotechnol; 2024 Jun; 66(6):1376-1388. PubMed ID: 37344711
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gene-deleted live-attenuated Trypanosoma cruzi parasites as vaccines to protect against Chagas disease.
    Sánchez-Valdéz FJ; Pérez Brandán C; Ferreira A; Basombrío MÁ
    Expert Rev Vaccines; 2015 May; 14(5):681-97. PubMed ID: 25496192
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From proteome to candidate vaccines: target discovery and molecular dynamics-guided multi-epitope vaccine engineering against kissing bug.
    Albaqami FF; Altharawi A; Althurwi HN; Alharthy KM
    Front Immunol; 2024; 15():1413893. PubMed ID: 38915396
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming.
    Hoft DF; Eickhoff CS; Giddings OK; Vasconcelos JR; Rodrigues MM
    J Immunol; 2007 Nov; 179(10):6889-900. PubMed ID: 17982080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An immunoinformatic approach for identification of Trypanosoma cruzi HLA-A2-restricted CD8(+) T cell epitopes.
    Eickhoff CS; Van Aartsen D; Terry FE; Meymandi SK; Traina MM; Hernandez S; Martin WD; Moise L; De Groot AS; Hoft DF
    Hum Vaccin Immunother; 2015; 11(9):2322-8. PubMed ID: 26107442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vaccine development against Trypanosoma cruzi and Leishmania species in the post-genomic era.
    Dumonteil E
    Infect Genet Evol; 2009 Dec; 9(6):1075-82. PubMed ID: 19805015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of B- and T-cell responses to cruzipain in the murine model of Trypanosoma cruzi infection.
    Schnapp AR; Eickhoff CS; Scharfstein J; Hoft DF
    Microbes Infect; 2002 Jul; 4(8):805-13. PubMed ID: 12270727
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Computational Prediction of Trypanosoma cruzi Epitopes Toward the Generation of an Epitope-Based Vaccine Against Chagas Disease.
    Ros-Lucas A; Rioja-Soto D; Gascón J; Alonso-Padilla J
    Methods Mol Biol; 2023; 2673():487-504. PubMed ID: 37258934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
    Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
    Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Genetic Validation of Chemotherapeutic Targets for Chagas' Disease.
    Osorio-Méndez JF; Cevallos AM
    Front Cell Infect Microbiol; 2018; 8():439. PubMed ID: 30666299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preventive and therapeutic DNA vaccination partially protect dogs against an infectious challenge with Trypanosoma cruzi.
    Quijano-Hernández IA; Castro-Barcena A; Vázquez-Chagoyán JC; Bolio-González ME; Ortega-López J; Dumonteil E
    Vaccine; 2013 Apr; 31(18):2246-52. PubMed ID: 23499599
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunity and vaccine development efforts against Trypanosoma cruzi.
    Rios LE; Vázquez-Chagoyán JC; Pacheco AO; Zago MP; Garg NJ
    Acta Trop; 2019 Dec; 200():105168. PubMed ID: 31513763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative Analysis of the Secretome and Interactome of
    Watanabe Costa R; Batista MF; Meneghelli I; Vidal RO; Nájera CA; Mendes AC; Andrade-Lima IA; da Silveira JF; Lopes LR; Ferreira LRP; Antoneli F; Bahia D
    Front Immunol; 2020; 11():1774. PubMed ID: 32973747
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complexes of Trypanosoma cruzi sterol 14α-demethylase (CYP51) with two pyridine-based drug candidates for Chagas disease: structural basis for pathogen selectivity.
    Hargrove TY; Wawrzak Z; Alexander PW; Chaplin JH; Keenan M; Charman SA; Perez CJ; Waterman MR; Chatelain E; Lepesheva GI
    J Biol Chem; 2013 Nov; 288(44):31602-15. PubMed ID: 24047900
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cruzipain and Its Physiological Inhibitor, Chagasin, as a DNA-Based Therapeutic Vaccine Against
    Cerny N; Bivona AE; Sanchez Alberti A; Trinitario SN; Morales C; Cardoso Landaburu A; Cazorla SI; Malchiodi EL
    Front Immunol; 2020; 11():565142. PubMed ID: 33162979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.